Oncology News | pharmaphorum

News

The FDA's cancer drugs committee backs AstraZeneca's Truqap in prostate cancer, but is unmoved by data for breast cancer candidate camizestrant.

News

AstraZeneca has delivered a much-needed boost to the UK government alongside a strong set of first-quarter results.

News

The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.

News

A study has found evidence that 11 cancers are becoming more common among young people in England, and points to a main driving factor.

News

With the ink barely dry on a deal to buy Kelonia, Lilly has signed a $2.3bn deal to acquire Ajax Therapeutics and its JAK2 blood cancer therapy.

News

A court ruling in the US has delivered a setback for GSK and its Tesaro subsidiary in their dispute with AnaptysBio over cancer drug Jemperli.